Insulin Resistance Syndrome: Difference between revisions
imported>Nancy Sculerati MD No edit summary |
imported>Nancy Sculerati MD No edit summary |
||
| Line 1: | Line 1: | ||
The '''insulin resistance syndrome''' is a "constellation of findings, including [[central obesity]], [[glucose intolerance]], [[dyslipidemia]], and [[hypertension]], that promotes the development of [[type 2 diabetes mellitus]], [[cardiovascular disease]], [[Cancer|cancer]], polycystic ovarian disease (PCOS), and nonalcoholic fatty liver disease".(reference for quote: Sudha B. Biddinger & C. Ronald Kahn : FROM MICE TO MEN: Insights into the Insulin Resistance Syndromes.Annual Review of Physiology | The '''insulin resistance syndrome''' is a "constellation of findings, including [[central obesity]], [[glucose intolerance]], [[dyslipidemia]], and [[hypertension]], that promotes the development of [[type 2 diabetes mellitus]], [[cardiovascular disease]], [[Cancer|cancer]], polycystic ovarian disease (PCOS), and nonalcoholic fatty liver disease".(reference for quote: Sudha B. Biddinger & C. Ronald Kahn : FROM MICE TO MEN: Insights into the Insulin Resistance Syndromes.Annual Review of Physiology Vol. 68: 123-158 (Volume publication date January 2006) (doi:10.1146/annurev.physiol.68.040104.124723)). As [[Obesity|obesity]] has reached epidemic proportions in many countries of the developed world, a pattern of these findings has become recognized. Also called the metabolic syndrome, the dysmetabolic syndrome, or syndrome, this association of [[Physiology|physiologic findings]] is the focus of current research in [[medicine]]. | ||
Vol. 68: 123-158 (Volume publication date January 2006) (doi:10.1146/annurev.physiol.68.040104.124723)) | |||
Revision as of 18:20, 26 January 2007
The insulin resistance syndrome is a "constellation of findings, including central obesity, glucose intolerance, dyslipidemia, and hypertension, that promotes the development of type 2 diabetes mellitus, cardiovascular disease, cancer, polycystic ovarian disease (PCOS), and nonalcoholic fatty liver disease".(reference for quote: Sudha B. Biddinger & C. Ronald Kahn : FROM MICE TO MEN: Insights into the Insulin Resistance Syndromes.Annual Review of Physiology Vol. 68: 123-158 (Volume publication date January 2006) (doi:10.1146/annurev.physiol.68.040104.124723)). As obesity has reached epidemic proportions in many countries of the developed world, a pattern of these findings has become recognized. Also called the metabolic syndrome, the dysmetabolic syndrome, or syndrome, this association of physiologic findings is the focus of current research in medicine.